Plantarc Bio Ltd. Logo

Plantarc Bio Ltd.

PLNT | TA

Overview

Corporate Details

ISIN(s):
IL0011714040
LEI:
Country:
Israel
Address:
Birkat Am St 61-63, 4390500 Giv’at Hen
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Plantarc Bio Ltd. is an agricultural biotechnology company focused on enhancing global food security through genetic innovation. The company utilizes proprietary platforms, including Direct-In-Plant (DIP™) for gene discovery and DIPPER™ for gene-editing optimization, to improve crop performance and resilience to climate change. Its primary activities involve identifying and developing novel genes that enhance traits such as yield, drought resistance, herbicide tolerance, and insect resistance. Additionally, Plantarc Bio develops RNAi-based products for biological pest control and yield enhancement in key crops like canola, soy, and rice. The company collaborates with global seed and agricultural firms to integrate its technologies and traits into commercial products, advancing sustainable agriculture.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Plantarc Bio Ltd.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2023-03-14 11:09
Investor Presentation
Presentation-World Agri-Tech Innovation Summit
English 9.4 MB
2023-03-14 11:09
Regulatory News Service
Presentation-World Agri-Tech Innovation Summit
Russian 43.3 KB
2022-01-27 14:21
Regulatory News Service
Plantarc – Appointment of a Market Maker, will not be included in the illiquid …
Hebrew (modern) 256.9 KB
2021-01-06 15:29
Regulatory News Service
On Thursday, 7 January 2021, trading will commence in the following Security: P…
Hebrew (modern) 174.5 KB
2021-01-04 17:13
Regulatory News Service
Identifying Details of New Security -PLANT ARC, PLANT ARC W1
Hebrew (modern) 178.5 KB
2020-11-18 16:16
Investor Presentation
Investor Presentation
English 1.8 MB
2020-11-18 16:16
Pre-Annual General Meeting Information
Investor Presentation
Russian 42.7 KB

Automate Your Workflow. Get a real-time feed of all Plantarc Bio Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Plantarc Bio Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NextCell Pharma AB Logo
Develops MSC therapies for autoimmune diseases and offers private stem cell banking services.
Sweden NXTCL
NextGen Biomed Ltd. Logo
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel NXGN
NFL Biosciences Logo
Develops botanical drug candidates to treat smoking and alcohol addictions for pharma licensing.
France ALNFL
Nicox S.A. Logo
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France COX
Nortem BioGroup Logo
Biotech R&D of natural products for consumer health, home, and animal nutrition.
Spain MLBIO
NRGene Technologies Ltd. Logo
AI genomics software accelerating plant & animal breeding for the agriculture industry.
Israel NRGN
NUFORMIX PLC Logo
A pharma firm repurposing drugs for fibrosis and oncology via proprietary cocrystal technology.
United Kingdom NFX
Nykode Therapeutics ASA Logo
Developing targeted immunotherapies and vaccines for cancer and infectious diseases.
Norway NYKD
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive drugs for sight-threatening eye diseases.
Switzerland OCS
ONCIMMUNE HOLDINGS PLC Logo
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom ONC